loading
前日終値:
$59.36
開ける:
$59.4
24時間の取引高:
56,448
Relative Volume:
0.13
時価総額:
$3.62B
収益:
$101.78M
当期純損益:
$-259.43M
株価収益率:
-18.27
EPS:
-3.28
ネットキャッシュフロー:
$-163.06M
1週間 パフォーマンス:
+0.29%
1か月 パフォーマンス:
+19.44%
6か月 パフォーマンス:
+57.71%
1年 パフォーマンス:
+79.42%
1日の値動き範囲:
Value
$57.99
$60.07
1週間の範囲:
Value
$55.37
$60.79
52週間の値動き範囲:
Value
$31.52
$68.58

Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile

Name
名前
Rhythm Pharmaceuticals Inc
Name
セクター
Healthcare (1195)
Name
電話
857-264-4280
Name
住所
222 BERKELEY STREET, BOSTON, MA
Name
職員
226
Name
Twitter
@rhythmpharma
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
RYTM's Discussions on Twitter

RYTM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RYTM 59.92 3.62B 101.78M -259.43M -163.06M -3.28
VRTX 446.83 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.22 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 592.15 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 249.71 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 104.52 24.89B 3.30B -501.07M 1.03B 11.54

Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-08 ダウングレード BofA Securities Buy → Neutral
2023-12-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-08-01 アップグレード BofA Securities Neutral → Buy
2023-01-18 再開されました Canaccord Genuity Buy
2022-08-08 アップグレード Goldman Neutral → Buy
2022-08-05 アップグレード BofA Securities Underperform → Neutral
2022-06-17 繰り返されました Needham Buy
2022-03-02 再開されました Stifel Buy
2022-02-17 アップグレード Ladenburg Thalmann Neutral → Buy
2021-12-08 開始されました Wells Fargo Overweight
2021-11-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-09-14 再開されました Goldman Neutral
2021-08-04 ダウングレード BofA Securities Neutral → Underperform
2021-08-04 ダウングレード Ladenburg Thalmann Buy → Neutral
2020-11-30 ダウングレード BofA Securities Buy → Neutral
2020-01-08 開始されました Goldman Sell
2019-07-12 アップグレード Stifel Hold → Buy
2019-07-08 開始されました Canaccord Genuity Buy
2019-03-13 開始されました Ladenburg Thalmann Buy
2018-09-07 再開されました Morgan Stanley Overweight
2018-06-25 繰り返されました Needham Buy
2018-06-15 繰り返されました Needham Buy
2017-10-30 開始されました BofA/Merrill Buy
2017-10-30 開始されました Needham Buy
すべてを表示

Rhythm Pharmaceuticals Inc (RYTM) 最新ニュース

pulisher
07:38 AM

Primecap Management Co. CA Has $378.09 Million Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

07:38 AM
pulisher
Nov 18, 2024

Rhythm Pharmaceuticals Announces Five Presentations at ESPE - GlobeNewswire

Nov 18, 2024
pulisher
Nov 18, 2024

Rhythm Pharma: New Drug Shows 9.6% Weight Loss in Pediatric Obesity Treatment Study | RYTM Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in Rhythm Pharma - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

(RYTM) Proactive Strategies - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Rhythm pharmaceuticals CTO Joseph Shulman sells $882,340 in stock By Investing.com - Investing.com Nigeria

Nov 14, 2024
pulisher
Nov 13, 2024

Rhythm pharmaceuticals CTO Joseph Shulman sells $882,340 in stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Rhythm Pharmaceuticals EVP sells $4.43m in stock By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Rhythm Pharmaceuticals EVP sells $4.43m in stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Rhythm Pharmaceuticals Announces Publication of Results - GlobeNewswire

Nov 13, 2024
pulisher
Nov 13, 2024

Rhythm Pharma's Obesity Drug Shows 83% Success in Phase 3 Trial, FDA Priority Review Set | RYTM Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewswire

Nov 13, 2024
pulisher
Nov 13, 2024

Rhythm Pharmaceuticals Awards 15,750 RSUs to New Employees in Talent Acquisition Push | RYTM Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

PRIMECAP Management Adjusts Stake in Rhythm Pharmaceuticals - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Goldman Sachs Group Inc Reduces Stake in Rhythm Pharmaceuticals Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

High Growth Tech Stocks Featuring Three Prominent US Companies - Simply Wall St

Nov 12, 2024
pulisher
Nov 11, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 52-Week HighWhat's Next? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

HC Wainwright Issues Pessimistic Outlook for RYTM Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Rhythm Pharmaceuticals' HR chief Pamela Cramer sells $585,940 in stock By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 09, 2024

Insider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 4,688 Shares of Stock - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Rhythm Pharmaceuticals' HR chief Pamela Cramer sells $585,940 in stock - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $69.00 - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024
pulisher
Nov 07, 2024

Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance UK

Nov 07, 2024
pulisher
Nov 07, 2024

8,594 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Acquired by Creative Planning - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highligh - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

Earnings call: Rhythm Pharmaceuticals has reported a successful third quarter in 2024 - Investing.com India

Nov 06, 2024
pulisher
Nov 06, 2024

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $64.00 at Needham & Company LLC - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Rhythm Pharmaceuticals CEO to Present at Major Healthcare Investor Conferences | RYTM Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 1-Year HighTime to Buy? - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Rhythm Pharma stock soars to all-time high of $55.65 By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Rhythm Pharma stock soars to all-time high of $55.65 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

Nov 05, 2024
pulisher
Nov 04, 2024

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading 7.4% HigherTime to Buy? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024 - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

What's Next: Rhythm Pharmaceuticals's Earnings Preview - Benzinga

Nov 04, 2024
pulisher
Nov 04, 2024

(RYTM) Investment Analysis - Stock Traders Daily

Nov 04, 2024
pulisher
Nov 03, 2024

Assenagon Asset Management S.A. Decreases Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Nisa Investment Advisors LLC Has $3.47 Million Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

Nov 02, 2024
pulisher
Oct 30, 2024

Needham & Company LLC Reaffirms Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 30, 2024

Rhythm Pharmaceuticals Inc (RYTM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rhythm Pharmaceuticals Inc (RYTM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Lee Jennifer Kayden
EVP, Head of North America
Nov 11 '24
Sale
66.33
66,861
4,434,882
972
Shulman Joseph
Chief Technical Officer
Nov 11 '24
Option Exercise
12.63
13,281
167,760
13,281
Shulman Joseph
Chief Technical Officer
Nov 11 '24
Sale
66.44
13,281
882,341
0
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):